Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest... -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
PARTITION FLASK
PARTITION FLASKVial containing a mixture of solvents to carry out a chromatographic separation ...

